• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过臭氧浸润降低拔牙后 MRONJ 的风险:一项随机临床试验。

Reduction of MRONJ risk after exodontia by virtue of ozone infiltration: A randomized clinical trial.

作者信息

Di Fede Olga, La Mantia Gaetano, Del Gaizo Carmine, Mauceri Rodolfo, Matranga Domenica, Campisi Giuseppina

机构信息

Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, Palermo, Italy.

Unit of Oral Medicine and Dentistry for Fragile Patients, Department of Rehabilitation, Fragility and Continuity of Care, University Hospital Palermo, Palermo, Italy.

出版信息

Oral Dis. 2024 Nov;30(8):5183-5194. doi: 10.1111/odi.15006. Epub 2024 May 29.

DOI:10.1111/odi.15006
PMID:38807567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11610715/
Abstract

INTRODUCTION

Exodontia is commonly considered as a risk factor for the development of medication-related osteonecrosis of the jaw (MRONJ) in individuals exposed to bone modifying agents. This study was aimed at assessing the efficiency and safety of a gaseous oxygen-ozone mixture as an adjuvant to a standard exodontia to reduce the risk of MRONJ development.

METHODS

A randomized, open-label, phase II, single-center clinical trial involving 117 patients at risk of MRONJ was conducted. The study protocol tested injections of an oxygen-ozone mixture in the post-extraction site. Participants were randomly assigned to two groups: oxygen-ozone therapy, and standard tooth extraction protocol. Post-extraction wound healing was assessed using the Inflammatory Proliferative Remodeling (IPR) Wound Healing Scale.

RESULTS

The oxygen-ozone therapy group exhibited a significant improvement in wound healing post-extraction during the inflammatory and proliferative phases, as indicated by the IPR scale scores at 3-5 days (p = 0.006) and 14 days (p < 0.001) respectively.

CONCLUSION

Oxygen-ozone therapy shows promise in improving post-extraction healing in patients at risk of MRONJ. Future studies with larger sample sizes and multicenter collaborations are recommended to confirm the validity of these findings and explore the long-term efficacy of ozone therapy.

摘要

引言

在暴露于骨改良剂的个体中,拔牙通常被认为是发生药物相关性颌骨坏死(MRONJ)的一个风险因素。本研究旨在评估气态氧 - 臭氧混合物作为标准拔牙辅助手段以降低MRONJ发生风险的有效性和安全性。

方法

进行了一项随机、开放标签、II期、单中心临床试验,纳入117名有MRONJ风险的患者。研究方案测试了在拔牙后部位注射氧 - 臭氧混合物。参与者被随机分为两组:氧 - 臭氧治疗组和标准拔牙方案组。使用炎症增殖重塑(IPR)伤口愈合量表评估拔牙后伤口愈合情况。

结果

氧 - 臭氧治疗组在拔牙后的炎症期和增殖期伤口愈合有显著改善,分别由IPR量表在3 - 5天(p = 0.006)和14天(p < 0.001)的评分表明。

结论

氧 - 臭氧治疗在改善有MRONJ风险患者的拔牙后愈合方面显示出前景。建议未来进行更大样本量和多中心合作的研究,以确认这些发现的有效性并探索臭氧治疗的长期疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e42/11610715/35d46d63033e/ODI-30-5183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e42/11610715/35d46d63033e/ODI-30-5183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e42/11610715/35d46d63033e/ODI-30-5183-g001.jpg

相似文献

1
Reduction of MRONJ risk after exodontia by virtue of ozone infiltration: A randomized clinical trial.通过臭氧浸润降低拔牙后 MRONJ 的风险:一项随机临床试验。
Oral Dis. 2024 Nov;30(8):5183-5194. doi: 10.1111/odi.15006. Epub 2024 May 29.
2
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究,探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素:原发伤口闭合和药物暂停真的能预防 MRONJ 吗?
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
3
Comparing the effects of low-level laser therapy and gaseous ozone as a preventive measure on medication-related osteonecrosis of the jaws following tooth extraction: a rat model.比较低水平激光治疗和气体臭氧作为预防措施对拔牙后药物相关性颌骨坏死的影响:大鼠模型。
Eur J Med Res. 2024 Jul 9;29(1):359. doi: 10.1186/s40001-024-01907-3.
4
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
5
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.抗吸收药物在骨质疏松症患者拔牙中应用与骨坏死的临床和 CBCT 评估:关键见解。
Osteoporos Int. 2024 Aug;35(8):1431-1440. doi: 10.1007/s00198-024-07108-2. Epub 2024 May 20.
6
Exosomes from Adipose-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw by Inhibiting Macrophage M1 Polarization and Pyroptosis.脂肪来源间充质基质细胞外泌体通过抑制巨噬细胞M1极化和焦亡预防药物相关性颌骨坏死
Int J Nanomedicine. 2024 Nov 26;19:12675-12693. doi: 10.2147/IJN.S482849. eCollection 2024.
7
Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.癌症患者拔牙后与药物相关的颌骨坏死:一项多中心回顾性研究。
Osteoporos Int. 2019 Jan;30(1):231-239. doi: 10.1007/s00198-018-4746-8. Epub 2018 Nov 7.
8
Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.低水平激光疗法通过 IL-1RA 介导的原发性牙龈创面愈合预防药物相关性颌骨样骨坏死性病变。
BMC Oral Health. 2023 Jan 10;23(1):14. doi: 10.1186/s12903-022-02678-1.
9
Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.拔牙后进行一期伤口缝合以预防接受地诺单抗治疗患者的药物相关性颌骨坏死
Clin Oral Investig. 2017 Jan;21(1):127-134. doi: 10.1007/s00784-016-1762-y. Epub 2016 Feb 29.
10
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.

引用本文的文献

1
Surgical extraction with photobiomodulation as an adjunctive modality in patients at-risk for medication-related osteonecrosis of the jaw: retrospective study.在有药物相关性颌骨坏死风险的患者中,以光生物调节作为辅助方式进行手术拔牙:一项回顾性研究。
BMC Oral Health. 2025 Apr 24;25(1):627. doi: 10.1186/s12903-025-05776-y.
2
Advancements in Bone Replacement Techniques-Potential Uses After Maxillary and Mandibular Resections Due to Medication-Related Osteonecrosis of the Jaw (MRONJ).骨替代技术的进展——颌骨药物相关性骨坏死(MRONJ)导致上颌骨和下颌骨切除术后的潜在用途。
Cells. 2025 Jan 20;14(2):145. doi: 10.3390/cells14020145.
3

本文引用的文献

1
Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ).意大利关于药物相关性颌骨坏死 (MRONJ) 的立场文件 (SIPMO-SICMF)。
Oral Dis. 2024 Sep;30(6):3679-3709. doi: 10.1111/odi.14887. Epub 2024 Feb 5.
2
Prevention of Dry Socket with Ozone Oil-Based Gel after Inferior Third Molar Extraction: A Double-Blind Split-Mouth Randomized Placebo-Controlled Clinical Trial.下颌第三磨牙拔除后使用臭氧油基凝胶预防干槽症:一项双盲、分口、随机、安慰剂对照临床试验
Gels. 2023 Apr 1;9(4):289. doi: 10.3390/gels9040289.
3
Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients.
Full-Arch Rehabilitation Using Implant-Guided Surgery and Ozone Therapy to Prevent Complications in a Systemically Compromised Patient.
使用种植体引导手术和臭氧疗法进行全牙弓修复以预防全身状况不佳患者的并发症
Cureus. 2024 Dec 23;16(12):e76251. doi: 10.7759/cureus.76251. eCollection 2024 Dec.
4
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS.乳腺癌和前列腺癌患者CTIBL管理中的药物相关性骨坏死(MRONJ)。SIPMO和SIOMMMS联合报告
J Bone Oncol. 2024 Dec 16;50:100656. doi: 10.1016/j.jbo.2024.100656. eCollection 2025 Feb.
5
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw.《中国颌骨药物相关性骨坏死诊断与临床治疗专家共识》
J Bone Oncol. 2024 Nov 19;49:100650. doi: 10.1016/j.jbo.2024.100650. eCollection 2024 Dec.
接受抗吸收剂治疗的患者在拔牙后发生药物相关性颌骨坏死的风险 - 一项 240 例患者的回顾性研究。
Bone. 2023 May;170:116722. doi: 10.1016/j.bone.2023.116722. Epub 2023 Feb 28.
4
Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis.服用抗吸收药物患者的拔牙管理:一项证据图谱综述与荟萃分析
J Clin Med. 2022 Dec 28;12(1):239. doi: 10.3390/jcm12010239.
5
Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case Series.臭氧注射治疗颌骨坏死:病例系列
J Clin Med. 2022 Sep 9;11(18):5307. doi: 10.3390/jcm11185307.
6
Amoxicillin/Metronidazole Dose Impact as an Adjunctive Therapy for Stage II - III Grade C Periodontitis (Aggressive Periodontitis) at 3- And 6-Month Follow-Ups: a Systematic Review and Meta-Analysis.阿莫西林/甲硝唑剂量作为II - III期C级牙周炎(侵袭性牙周炎)辅助治疗在3个月和6个月随访时的影响:一项系统评价和荟萃分析。
J Oral Maxillofac Res. 2022 Mar 31;13(1):e2. doi: 10.5037/jomr.2022.13102. eCollection 2022 Jan-Mar.
7
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset.有颌骨药物相关性骨坏死风险的癌症患者。一项分析颌骨药物相关性骨坏死发病预测因素的病例对照研究。
J Clin Med. 2021 Oct 17;10(20):4762. doi: 10.3390/jcm10204762.
8
Efficacy of adjuvant ozone therapy in reducing postsurgical complications following impacted mandibular third-molar surgery: A systematic review and meta-analysis.辅助臭氧疗法在减少下颌阻生第三磨牙手术后术后并发症中的疗效:系统评价和荟萃分析。
J Am Dent Assoc. 2021 Oct;152(10):842-854.e1. doi: 10.1016/j.adaj.2021.05.006.
9
Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients' Gingiva.来源于双膦酸盐相关性颌骨骨坏死患者牙龈的间充质干细胞的特征。
Stem Cell Rev Rep. 2022 Jan;18(1):378-394. doi: 10.1007/s12015-021-10241-8. Epub 2021 Sep 22.
10
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients.拔牙与癌症患者药物相关性颌骨坏死发展的关系。
Sci Rep. 2021 Aug 26;11(1):17226. doi: 10.1038/s41598-021-96480-8.